MT Pharmacy

The Esentra 120 mg Injection contains the active ingredient denosumab, a monoclonal antibody used to treat various bone conditions and prevent bone complications associated with certain cancers

Nuclasta 60 mg Injection is a prescription medicine containing the active ingredient denosumab. It is a monoclonal antibody used primarily to treat osteoporosis (bone thinning) in postmenopausal women and men at high risk of fractures, as well as other conditions involving bone loss or bone tumors. 

The Denoci 120 mg Injection contains the active ingredient denosumab (120 mg) and belongs to a class of medicines called RANK ligand inhibitors. It is a monoclonal antibody used to treat various bone-related conditions by slowing down bone breakdown. 

The Olimab 60 mg Injection contains denosumab 60 mg as its active ingredient. It is a prescription medication classified as a monoclonal antibody (not chemotherapy) used to treat conditions involving bone loss and increased fracture risk by strengthening the bones. 

Denoclast 60 mg Injection is a prescription medication containing denosumab that is used to treat osteoporosis, reduce bone loss from certain cancer treatments, and manage high calcium levels caused by cancer. It works by inhibiting a protein called RANK ligand, which decreases bone breakdown and increases bone density. The injection must be administered by a healthcare professional. 

Exemptia 40 Mg Adalimumab Injection is a prescription biosimilar medication that contains the active ingredient adalimumab, a human monoclonal antibody and a type of medicine known as a TNF (tumor necrosis factor) inhibitor. It is manufactured by the pharmaceutical company Zydus Cadila. 

The Mabura 40 mg injection is a prescription medication containing the active ingredient adalimumab, a human monoclonal antibody. It is classified as a tumor necrosis factor (TNF) inhibitor, which means it works by suppressing the overactivity of the immune system to reduce inflammation, pain, swelling, and redness associated with various autoimmune disorders.